Fig. 2

The survival rate of cancer patients with respect to prognostic lncRNA-miRNA-mRNA triplets found in our study. Group 1: patients with opposite expression patterns of lncRNAs and mRNAs in the lncRNA-miRNA-mRNA triplet. Group 2: patients with similar expression patterns of lncRNAs and mRNAs in the lncRNA-miRNA-mRNA. A The survival rate of BRCA patients with respect to two lncRNA-miRNA-mRNA triplets (DIRC3_hsa-mir-183_PTP4A2 and DIRC3_hsa-mir-191_SLC16A2). B The survival rate of LIHC patients with respect to two lncRNA-miRNA-mRNA triplets (HAS2-AS1_hsa-mir-145_TGFB2 and AL139423.1_hsa-mir-150_HILPDA). C The survival rate of LUAD patients with respect to two lncRNA-miRNA-mRNA triplets (AC123768.4_hsa-mir-301b_ENPP5 and AC234582.1_hsa-mir-665_DNALI1)